Product Images Lacosamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Lacosamide NDC 43598-087 by Dr. Reddy's Laboratories Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton - carton

carton - carton

figure1 - figure1

figure1 - figure1

This is a description of a study evaluating the effect of Lacosamide on pain reduction. It indicates a statistically significant difference in pain reduction when compared to a placebo. The study seems to involve an analysis related to the use of Lacosamide for pain management.*

figure2 - figure2

figure2 - figure2

This is a comparison chart depicting responder rates (equal to or greater), improvement, and worsening for different dosages of lacosamide and a placebo. The data includes the number of patients in each group and the percentage of patients for each category. The different dosages of lacosamide evaluated are 200mg/day, 400mg/day, and 600mg/day, with varying numbers of patients in each group.*

figure3 - figure3

figure3 - figure3

This text provides information related to the proportion of patents, risk, p-value, hazard ratio, confidence interval, and time in days. The hazard ratio indicates a risk reduction of 45.2%, with a 95% confidence interval between 0.381 and 0.788. The p-value is 0.0001. Time (Days) is also mentioned.*

structure - structure

structure - structure

vial - vial

vial - vial

This is a description of a medication labeled as Lacosamide Injection, USP, with a concentration of 200 mg/20 mL. It is intended for intravenous use only and comes in a 20mL single-dose vial. The usual dosage information can be found in the package insert. Unused portions should be discarded, and the medication should be stored at a temperature between 20°C to 25°C. The medication is set to expire in October 2023 and is distributed by Dr. Reddy's Laboratories Inc. Made in India.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.